X-linked severe combined immunodeficiency disease (X-SCID) is a rare genetic disorder characterized by profound defects in ...

X-linked severe combined immunodeficiency disease (X-SCID) is a rare genetic disorder characterized by profound defects in T-cell, B-cell, and natural ...

Theratechnologies Inc.’s THTX share price has surged by 28.57%, which has investors questioning if this is right time to sell ...

Leiden, the Netherlands Saturday, March 22, 2025, 12:00 Hrs [IST] ...

Adma Biologics (ADMA) witnessed a jump in share price last session on above-average trading volume. The latest trend in ...

Police in Bauchi have arrested pharmacist Ibrahim Yahaya and Dr Musa Awwal, both staff of Abubakar Tafawa Balewa University ...

Operatives of the Bauchi State Police Command have arrested a pharmacist, Ibrahim Yahaya and Dr Musa Awwal, both staff of ...

X4 Pharmaceuticals highlights 2024 as transformative with XOLREMDI's U.S. launch, international expansion, & Phase 3 trial progress.

ADMA Biologics' differentiated products and strong patent portfolio support continued growth despite premium valuation. Learn ...

FDA & EMA approvals for rare genetic diseases are fast and require clinical studies with small number of patients Ramat Gan, Israel, March ...

Phase 3 4WARD trial in chronic neutropenia now activated at ~90% of targeted trial sites; full enrollment expected in 3Q or 4Q 2025; top-line ...